Navigation Links
Genes May Predict Lymphoma Treatment Outcome
Date:11/26/2008

Screens might be used to determine which patients will benefit, researchers say

WEDNESDAY, Nov. 26 (HealthDay News) -- Gene activity patterns can tell doctors whether people with a certain type of non-Hodgkin lymphoma have a better chance of survival with treatment, according to a new study.

Three different signatures of gene activity, or expression -- a measure of the biological activity of a gene -- have been identified in people with diffuse large B-cell lymphoma (DLBCL). One signature, stromal-2, was linked to poor prognosis.

In studying thousands of genes in DLBCL tumors, the researchers determined that nonmalignant immune and structural cells lying near the tumor cells also have a great effect on how well patients respond to therapy.

"These biological variations are significant in patients treated with the current standard of care," study leader Dr. Louis M. Staudt of the U.S. National Cancer Institute, said in a news release issued by the organization. "Our results provide many fresh ideas about how existing drugs might be utilized to overcome the remaining resistance of some DLBCL tumors to our current therapy."

The findings were published in the Nov. 27 issue of the New England Journal of Medicine.

Diffuse large B-cell lymphoma, an aggressive type of non-Hodgkin lymphoma with several subtypes, makes up 30 percent of all newly diagnosed cases. The standard treatment for DLBCL is a combination five drugs -- cyclophosphamide, hydroxydoxorubicin (doxorubicin, Adriamycin), Oncovin (vincristine), prednisone and rituximab. Known as R-CHOP, this treatment cures up to 60 percent of patients.

Combining the new gene signature model with the International Prognostic Index (IPI), an index to predict survival of DLBCL patients based on factors such as age, stage of the tumor and spread of the cancer, improved how well both models predicted prognosis. According to the researchers, this suggests that clinical factors as well as tumor characteristics each affect the outcomes of DLBCL patients receiving treatment.

More information

The Leukemia & Lymphoma Society has more about non-Hodgkin lymphoma.



-- Kevin McKeever



SOURCE: U.S. National Cancer Institute, news release, Nov. 26, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Pathway links inflammation, angiogenesis and breast cancer
2. Traffic Fumes Plus Genes Boosts Kids Asthma Risk
3. New Database to Help Speed Search for Bipolar Disorder Genes
4. Is Perfect Pitch All in the Genes?
5. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
6. Genes Boost Risk for Rheumatoid Arthritis, Lupus
7. The genes involved in rheumatoid arthritis identified
8. If you think cancer genes are simple, you dont know JAK
9. Test for lung cancer looks for discomforting quiet among protective genes
10. Hushed Genes Might Mean Higher Lung Cancer Risk
11. EURYI project to understand how the brain wires during embryogenesis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genes May Predict Lymphoma Treatment Outcome
(Date:10/13/2017)... ... October 13, 2017 , ... ... Arkansas that offers insurance and financial preparation services, is providing an update on ... Rescue organization. , Rock City Rescue is a locally recognized nonprofit that provides ...
(Date:10/13/2017)... Pa. (PRWEB) , ... October 13, 2017 , ... While ... dark poses a problem. Fortunately, an inventor from Austin, Texas, has identified a solution. ... to medication in darkness or restricted lighting. As such, it eliminates the need to ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... EDWARDSVILLE, Ill. (PRWEB) , ... ... ... University Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and ... educated healthcare professionals on guideline updates for the primary prevention of cardiovascular ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , ... mock evacuation of the facility as part of a disaster drill on October 3rd. ... EMS and Shelton City Emergency Manager, as well as the Connecticut Long Term ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
(Date:9/19/2017)... medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound energy ... ... Jim Bertolina, PhD ... Tom Tefft ... executive Josh Stopek , PhD, who has led R&D and business development teams at ...
(Date:9/13/2017)... Sept. 13, 2017   OrthoAtlanta has been named ... Football Host Committee (AFHC) for the 2018 College Football Playoff ... 2018, at Mercedes-Benz Stadium in Atlanta, Georgia ... AFHC "I,m In" campaign, participating in many activities leading up ... ...
Breaking Medicine Technology: